Spectrophotometric Methods for Simultaneous Estimation Of Pyrimethamine And Sulphadoxine In Bulk Drug And Pharmaceutical Formulations

Pharma courses

pharma courses



About Authors:
Kalpesh N. Patel1*, Jayvadan K. Patel2
1 Research Scholar, Jodhpur National University, Jodhpur,
Rajshathan, India
2 Department of Pharmaceutical Technology,

Nootan Pharmacy College,
Visnagar (GUJARAT), India.

Abstract
Two simple spectrophotometric methods have been developed for simultaneous estimation of pyrimethamine and sulphadoxine from tablet dosage form. Method-I simultaneous equation method involves the measurement of absorbances at two wavelengths 215 nm (λmax of pyrimethamine) and 254 nm (λmax of sulphadoxine) in methanol and Method-II first order derivative spectroscopic method involves the measurement of absorbances at two wavelengths 250 nm (λmax of pyrimethamine) and 220.5 nm (λmax of sulphadoxine); The linearity lies between 5-30 µg/ml for both pyrimethamine and sulphadoxine for all the two methods. The accuracy and precision of the methods were determined and validated stastically. All the methods showed good reproducibility and recovery with % RSD less than 2. All method were found to be rapid, specific, precise and accurate and can be successfully applied for the routine analysis of pyrimethamine and sulphadoxine in bulk and combined dosage form.

Reference Id: PHARMATUTOR-ART-1228

INTRODUCTION
Chemically, Pyrimethamine (PYR) is 5-(4-chlorophenyl)-6-ethyl-2,4-pyrimidinediamine[1].Itis a medication used for protozoal infections. It is commonly used as an antimalarial drug and is also used in the treatment of Toxoplasma gondii infections in immunocompromised patients, such as HIV-positive individuals[2]. Pyrimethamine alone or in combination with other drugs is reported to be estimated by Liquid chromatography[3-5], Gas –Liquid chromatography[6], liquid chromatography–mass spectrometry[7,8] and HPTLC method[9].
Chemically,Sulphadoxine (SULPH) is 4-Amino-N-(5,6-dimethoxy-4-pyrimidinyl)benzene sulfonamide. It is an ultra-long-lasting sulfonamide often used in combination with pyrimethamine to treat or prevent malaria. It is also used, usually in combination with other drugs, to treat or prevent various infections in livestock[10].Sulphadoxine alone or in combination with other drugs is reported to be estimated by Supercritical fluid chromatography[11], Spectrophotoscopy[12], Microbiological method[13] and Gas chromatography method[14].
Spectrophotometric method is reported for simultaneous estimation of pyrimethamine and sulphadoxine in combination in visible region by making complex. Therefore, the aim of this study is the development of simple, precise, rapid and accurate UV Spectrophotometric Methods for Simultaneous Estimationof Pyrimethamine and Sulphadoxine in Bulk Drug and Pharmaceutical formulations as per ICH guidelines which is easily acceptable as a routine in quality testing laboratories in industry and academic institutes[15].

MATERIALS & METHODS
Instrument, reagents and chemicals

A Shimadzu UV/Visible spectrophotometer, model No.UV-1800 was employed with spectral band width of 2 nm and wavelength accuracy of ± 0.1 nm, with automatic wavelength correction employing a pair of quartz cells. A Sartorius electronic analytical balance was used for weighing the sample. Pure drug sample of pyrimethamine and sulphadoxine were procured from Shreya Life Sciences Pvt. Ltd. Aurangabad, India. Tablet formulation containing Pyrimethamine (37.5mg) and Sulphadoxine (750 mg) was procured from local market. Methanol was used as solvent.

Preparation of stock solution
Standard stock solutions having 100μg/ml of Pyrimethamine and Sulphadoxine were prepared by dissolving separately 10 mg of each drug in 100 ml of methanol. The stock solutions were individually diluted to get final concentration of 10μg/ml each and the diluted solutions were scanned in 200-300 nm range to determine the maximum absorbance (λmax).

Simultaneous equation method (Method I):
From the stock solution of 100 μg/mL, working standard solutions of drugs were prepared by appropriate dilution and were scanned in entire UV range to determine the max. Pyrimethamine and Sulphadoxine have λmax at 215 nm and 254 nm; respectively [Figure 1].Standard solutions were prepared having concentration 5-30 μg/mL for both drugs. The absorbances of these standard solutions were measured at 215 nm and 254 nm, respectively to plot a calibration curve of absorbance versus concentration. The calibration curves were found to be linear in the concentration range under study. Absorptivities values of Pyrimethamine and Sulphadoxine were determined at selected wavelengths and are presented in Table-1.

Two simultaneous equations (in two variables C1 and C2) were formed using these Absorptivity coefficient values.

A1 = ax1CPYR + ax2CSULPH  ………(1)

A1 = ay1CPYR + ay2CSULPH ……….(2)

Where, A1 and A2 are the absorbance of the mixture at 215 nm and 254 nm respectively. ax1and ay1are absorptivities of PYR at 215 nm and 254nm respectively. ax2and ay2 are absorptivities of SULPH at 215 nm and 254 nm respectively. CPYR is the concentration of PYR and CSULPH is the concentration of SULPH in μg/ml.

By applying the cramer’s rule to equation 1 and 2, the concentration CPYR and CSULPH can be obtained as follows.

                    ax1A2 -  ax2A1
CSULPH  =  ----------------------       
……..(3)
                   ax1 ay2  - ax2 ay1

   And,

                ay2A1 -  ay1A2
CPYR   = ----------------------           ………..(4)
               ax1 ay2  - ax2 ay1

First derivative spectroscopy method (Method II):
Standard stock solutions having 100μg/ml of Pyrimethamine and Sulphadoxine were prepared by dissolving separately 10 mg of each drug in 100 ml of methanol. The stock solutions were individually diluted to get final concentration of 10μg/ml each and the diluted solutions were scanned in 200-300 nm range. Data was recorded at the internal of 2nm.Then the spectra of the two drugs were derivatised to obtain first order derivative spectra. After examining the overlain first order derivative spectra, wavelengths were selected where one drug showed zero crossing and other drug showed substantial absorbance. The wavelength selected for Pyrimethamine analysis was 250 nm where Sulphadoxine has zero absorbance and the wavelength selected for Sulphadoxine analysis was 220.5 nm where the absorbance of Pyrimethamine is zero. The derivative spectra of the drugs are shown in Figure 2. Standard solutions were prepared having concentration 5-30 μg/mL for both drugs. The absorbances of these standard solutions were measured at 250 nm and 220.5 nm, respectively to plot a calibration curve of absorbance versus concentration. The calibration curves were found to be linear in the concentration range under study.

NOW YOU CAN ALSO PUBLISH YOUR ARTICLE ONLINE.

SUBMIT YOUR ARTICLE/PROJECT AT articles@pharmatutor.org

Subscribe to Pharmatutor Alerts by Email

FIND OUT MORE ARTICLES AT OUR DATABASE


 

Pages

FIND MORE ARTICLES